Showing results (31-40 of 502) with videos related to
Sort By:
Pageof 51
Leukemia Research Reports|June 28, 2024
Central nervous system relapse after combination therapy including polatuzumab vedotin in patients with diffuse large B-cell lymphomaYoshikazu Hori, Hiroki Hosoi, Toshiki Mushino, et al.Leukemia Research Reports|June 21, 2021
Distal chromosome 1q aberrations and initial response to ibrutinib in central nervous system relapsed mantle cell lymphomaMarcus Høy Hansen, Karen Juul-Jensen, Oriane Cédile, et al.Leukemia Research Reports|September 19, 2018
Renal infiltration presenting as acute kidney injury in Hodgkin lymphoma - A case report and review of the literatureWellington Fernandes da Silva, Laila Lopes de Farias Pinho, Cássio Lins Gil de Farias, et al.Leukemia Research Reports|May 19, 2022
CSF3R T618I mutated chronic myelomonocytic leukemia: A proliferative subtype with a distinct mutational profileAdelaide Kwon, Ibrahim Ibrahim, Tri Le, et al.Leukemia Research Reports|May 11, 2022
Current and emerging monoclonal antibodies, antibody-drug conjugates, and bispecific antibodies in treatment of lymphomaSuheil Albert Atallah-Yunes, Michael J RobertsonLeukemia Research Reports|December 12, 2018
The rare translocation t(14;21)(q11;q22) detected in a Moroccan patient with T-cell acute lymphoblastic leukemiaZ Takki Chebihi, A Belkhayat, E Chadli, et al.Leukemia Research Reports|June 6, 2022
Immunotherapy in indolent Non-Hodgkin's LymphomaGhid Amhaz, Ali Bazarbachi, Jean El-CheikhLeukemia Research Reports|June 13, 2022
Daratumumab triplet therapies in patients with relapsed or refractory multiple myeloma: A "real world" experienceLudovica Fucci, Lorenzo Gensini, Ugo Coppetelli, et al.Leukemia Research Reports|May 27, 2021
An unusual case of chronic lymphocytic leukemia with trisomy 12 and t(14;18) and a favorable response to ibrutinibFady Gh Haddad, Alain Chebly, Antoine El Sett, et al.Leukemia Research Reports|May 27, 2021
Successful treatment of "accelerated" chronic lymphocytic leukemia with single agent ibrutinib: A report of two casesJohn Xie, Albert Jang, Andrew Vegel, et al.Pageof 51